Read more

Reslizumab: First Global Approval.

Related ArticlesReslizumab: First Global Approval.
Drugs. 2016 Apr 28;
Authors: Markham A
Abstract
Reslizumab (Cinqair(®)) is a humanised monoclonal interleukin-5 (IL-5) antibody developed by Teva that has…

Read more

Selexipag: First Global Approval.

Related ArticlesSelexipag: First Global Approval.
Drugs. 2016 Feb 4;
Authors: Scott LJ
Abstract
Selexipag (Uptravi(®)) is a highly selective, long-acting, nonprostanoid, prostacyclin receptor agonist that …